Literature DB >> 23423536

Nontraumatic subarachnoid hemorrhage of the convexity.

Verónica Andrea Bruno1, Virginia Pujol Lereis, Maximiliano Hawkes, Sebastián Francisco Ameriso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23423536     DOI： 10.1007/s11910-013-0338-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  15 in total

1.  Subarachnoid haemorrhage treated with anticoagulants.

Authors:  A Ciccone; A Citterio; I Santilli; R Sterzi
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

2.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

Review 3.  Nonaneurysmal convexity subarachnoid hemorrhage.

Authors:  Kalpesh C Patel; Pasquale F Finelli
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Cerebral amyloid angiopathy with symptomatic or occult subarachnoid haemorrhage.

Authors:  K Karabatsou; B R F Lecky; N G Rainov; J C Broome; R P White
Journal:  Eur Neurol       Date:  2006-12-15       Impact factor: 1.710

Review 5.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

6.  Convexity subarachnoid haemorrhage associated with bilateral internal carotid artery stenoses.

Authors:  Timothy John Kleinig; Thomas Edward Kimber; Philip Douglas Thompson
Journal:  J Neurol       Date:  2009-04-23       Impact factor: 4.849

7.  Clinical presentation, etiology, and long-term prognosis in patients with nontraumatic convexal subarachnoid hemorrhage.

Authors:  Markus Beitzke; Thomas Gattringer; Christian Enzinger; Gerit Wagner; Kurt Niederkorn; Franz Fazekas
Journal:  Stroke       Date:  2011-09-15       Impact factor: 7.914

8.  Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies.

Authors:  S Kumar; R P Goddeau; M H Selim; A Thomas; G Schlaug; A Alhazzani; D E Searls; L R Caplan
Journal:  Neurology       Date:  2010-03-16       Impact factor: 9.910

9.  Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors.

Authors:  Anne Ducros; Ursula Fiedler; Raphael Porcher; Monique Boukobza; Christian Stapf; Marie-Germaine Bousser
Journal:  Stroke       Date:  2010-09-30       Impact factor: 7.914

10.  Non-traumatic cortical subarachnoid haemorrhage: diagnostic work-up and aetiological background.

Authors:  C Spitzer; M Mull; V Rohde; C M Kosinski
Journal:  Neuroradiology       Date:  2005-06-22       Impact factor: 2.804
View more
  2 in total

1.  Multifocal Atraumatic Convexity Subarachnoid Hemorrhage.

Authors:  Katarina B Dakay; Idrees Azher; Ali Mahta; Karen Furie; Shadi Yaghi; Shawna M Cutting
Journal:  Cureus       Date:  2021-07-01

2.  Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis.

Authors:  Isabel Charlotte Hostettler; Duncan Wilson; Catherine Arnold Fiebelkorn; Diane Aum; Sebastián Francisco Ameriso; Federico Eberbach; Markus Beitzke; Timothy Kleinig; Thanh Phan; Sarah Marchina; Romain Schneckenburger; Maria Carmona-Iragui; Andreas Charidimou; Isabelle Mourand; Sara Parreira; Gareth Ambler; Hans Rolf Jäger; Shaloo Singhal; John Ly; Henry Ma; Emmanuel Touzé; Ruth Geraldes; Ana Catarina Fonseca; Teresa Melo; Pierre Labauge; Pierre-Henry Lefèvre; Anand Viswanathan; Steven Mark Greenberg; Juan Fortea; Marion Apoil; Marion Boulanger; Fausto Viader; Sandeep Kumar; Velandai Srikanth; Ashan Khurram; Franz Fazekas; Veronica Bruno; Gregory Joseph Zipfel; Daniel Refai; Alejandro Rabinstein; Jonathan Graff-Radford; David John Werring
Journal:  J Neurol       Date:  2021-07-17       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.